1. Diagnosis, prognosis, and molecular mechanisms behind the development of diabetic neuropathy 2. Detection and grading of diabetic neuropathy using skin biopsies and corneal confocal microscopy 3. Pathogenesis and novel therapeutic approaches of diabetic neuropathy in Retina 4. Nrf2 as a potential therapeutic target for diabetic nephropathy 5. Roles of exercise and weight loss in the management of diabetic neuropathy 6. Roles of tricyclic antidepressants, serotonin or adrenaline (norepinephrine) reuptake inhibitors and gabapentin analogues for treating diabetic neuropathy 7. Pain management in diabetic neuropathy.

What are the challenges? 8. Lipids as a therapeutic target in diabetic neuropathy 9. Roles of microRNAs in diabetic neuropathy 10. Roles of lidocaine, capsaicin, clonidine, amitriptyline, and ketamine in the management of diabetic neuropathic pain 11. Gene Therapy. A novel therapeutic target for the management of diabetic neuropathy 12. Inflammation. A therapeutic target for diabetic neuropathy 13.

Matrix metalloproteinases as a potential therapeutic target for diabetic neuropathic pain 14. Heme oxygenase 1 as a novel target for the treatment of diabetic peripheral neuropathy 15. Voltage gated sodium channel as a therapeutic target for the painful diabetic neuropathy 16. Endoplasmic Reticulum Stress as a target for the treatment of peripheral diabetic neuropathy 17. Sirtuins and Nrf2 as SIRT1 activators as emerging treatments for diabetic neuropathy 18. mTOR signalling pathway as a potential mechanism and therapeutic target for diabetic small fiber neuropathy 19. Polyphenols and phenolic acids as therapeutic approach for the management of diabetic neuropathy 20. Alpha Lipoic acid as a therapeutic approach for the treatment of diabetic peripheral neuropathy.